de Boer, Pieter T <br/><br/>
Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.  [electronic resource] 

 -  BMC medicine  12 2018 
 - 228 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1741-7015 
<br/><br/><label>Standard No.: </label>10.1186/s12916-018-1213-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--economics<br/>Aged<br/>Aged, 80 and over<br/>Cost-Benefit Analysis--methods<br/>Female<br/>Herpes Zoster--drug therapy<br/>Herpes Zoster Vaccine--economics<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Quality of Life<br/>Vaccines, Attenuated--economics